State Street’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $975K | Buy |
|
|||||
|
2025
Q2 | $424K | Sell |
|
|||||
|
2025
Q1 | $342K | Sell |
|
|||||
|
2024
Q4 | $371K | Buy |
|
|||||
|
2024
Q3 | $690K | Buy |
|
|||||
|
2024
Q2 | $519K | Buy |
|
|||||
|
2024
Q1 | $386K | Hold |
|
|||||
|
2023
Q4 | $268K | Hold |
|
|||||
|
2023
Q3 | $310K | Hold |
|
|||||
|
2023
Q2 | $232K | Sell |
|
|||||
|
2023
Q1 | $365K | Hold |
|
|||||
|
2022
Q4 | $196K | Hold |
|
|||||
|
2022
Q3 | $283K | Hold |
|
|||||
|
2022
Q2 | $228K | Hold |
|
|||||
|
2022
Q1 | $280K | Buy |
|
|||||
|
2021
Q4 | $329K | Hold |
|
|||||
|
2021
Q3 | $616K | Hold |
|
|||||
|
2021
Q2 | $508K | Sell |
|
|||||
|
2021
Q1 | $1.33M | Sell |
|
|||||
|
2020
Q4 | $1.5M | Sell |
|
|||||
|
2020
Q3 | $1.86M | Buy |
|
|||||
|
2020
Q2 | $2.11M | Buy |
|
|||||
|
2020
Q1 | $1.3M | Sell |
|
|||||
|
2019
Q4 | $1.92M | Buy |
|
|||||
|
2019
Q3 | $2.04M | Buy |
|
|||||
|
2019
Q2 | $2.14M | Buy |
|
|||||
|
2019
Q1 | $503K | Buy |
|
|||||
|
2018
Q4 | $335K | Buy |
|
|||||
|
2018
Q3 | $261K | Sell |
|
|||||
|
2018
Q2 | $303K | Buy |
|
|||||
|
2018
Q1 | $83K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $26K | Hold |
|
|||||
|
2017
Q2 | $28K | Hold |
|
|||||
|
2017
Q1 | $27K | Hold |
|
|||||
|
2016
Q4 | $11K | Hold |
|
|||||
|
2016
Q3 | $13K | Sell |
|
|||||
|
2016
Q2 | $17K | Hold |
|
|||||
|
2016
Q1 | $17K | Hold |
|
|||||
|
2015
Q4 | $18K | Hold |
|
|||||
|
2015
Q3 | $28K | Hold |
|
|||||
|
2015
Q2 | $33K | Sell |
|
|||||
|
2015
Q1 | $686K | Buy |
|
|||||
|
2014
Q4 | $681K | Buy |
|
|||||
|
2014
Q3 | $879K | Buy |
|
|||||
|
2014
Q2 | $2.35M | Buy |
|